Dade Behring sales grow but profits hit by charge
This article was originally published in Clinica
Executive Summary
Dade Behring reported 9% revenue growth in the second quarter as its core chemistry business continued to perform healthily. The company's Dimension analyser family maintained double-digit growth, contrasting with rival Beckman Coulter's disappointing performance in laboratory automation.